Outsourcing of Genetic Testing

Location

Description

Following the relocation of the All Wales Genomics Laboratory Service (AWMGS) to Cardiff Edge—a strategic move designed to strengthen long-term service capacity and foster innovation—the service has experienced a significant backlog of genetic tests.This backlog has arisen due to the complexities involved in transitioning laboratory operations, revalidating testing protocols, and managing sustained growth in clinical demand across Wales.Although progress has been made in stabilising operations since the move, current in-house capacity remains insufficient to consistently meet the turnaround times required for timely, accurate, and equitable patient diagnosis. To reduce the risk of delayed diagnoses and potential impacts on patient outcomes, it is necessary to continue outsourcing genetic testing to SNB Diagnostics Globales S.A.U May 2027.This extension will allow AWMGS to recover operationally, maintain continuity of service delivery, uphold clinical standards, and ensure that patients across Wales have fair and timely access to essential genetic testing services.Failure to maintain this outsourced provision would place the laboratory in an unrecoverable operational position, with serious consequences for service resilience and patient care.

Award Detail

CPV Codes

• None found

Legal Justification

The use of a single supplier is justified on the grounds of both technical necessity and exclusive rights. The appointed provider has established, specialist methodologies, validated processes, and proprietary know‑how (including intellectual property) that cannot be replicated or transferred without significant risk to service quality and continuity. In addition, there are strong technical reasons to maintain continuity with this supplier, including the need for consistency in testing methodology, result interpretation, and quality assurance. Changing provider would introduce unacceptable delays, revalidation requirements, and potential risks to patient outcomes. As a result, no reasonable alternative or substitute exists that can deliver the service to the required clinical, technical, and timescale standards, making the single supplier approach necessary and proportionate.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **